GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » PS Ratio

Innovative Pharmaceutical Biotech (HKSE:00399) PS Ratio : 83.00 (As of Apr. 23, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Innovative Pharmaceutical Biotech's share price is HK$0.166. Innovative Pharmaceutical Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.00. Hence, Innovative Pharmaceutical Biotech's PS Ratio for today is 83.00.

Good Sign:

Innovative Pharmaceutical Biotech Ltd stock PS Ratio (=55.33) is close to 1-year low of 51.67.

The historical rank and industry rank for Innovative Pharmaceutical Biotech's PS Ratio or its related term are showing as below:

HKSE:00399' s PS Ratio Range Over the Past 10 Years
Min: 13   Med: 35.33   Max: 105
Current: 83

During the past 13 years, Innovative Pharmaceutical Biotech's highest PS Ratio was 105.00. The lowest was 13.00. And the median was 35.33.

HKSE:00399's PS Ratio is ranked worse than
99.91% of 1110 companies
in the Retail - Cyclical industry
Industry Median: 0.635 vs HKSE:00399: 83.00

Innovative Pharmaceutical Biotech's Revenue per Sharefor the six months ended in Sep. 2024 was HK$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.00.

Warning Sign:

Innovative Pharmaceutical Biotech Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Innovative Pharmaceutical Biotech was -60.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -33.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -23.50% per year.

During the past 13 years, Innovative Pharmaceutical Biotech's highest 3-Year average Revenue per Share Growth Rate was 122.00% per year. The lowest was -79.00% per year. And the median was -18.75% per year.

Back to Basics: PS Ratio


Innovative Pharmaceutical Biotech PS Ratio Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech PS Ratio Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.50 24.90 24.83 34.67 66.67

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 34.67 - 66.67 -

Competitive Comparison of Innovative Pharmaceutical Biotech's PS Ratio

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's PS Ratio Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's PS Ratio distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's PS Ratio falls into.


;
;

Innovative Pharmaceutical Biotech PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Innovative Pharmaceutical Biotech's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.166/0.002
=83.00

Innovative Pharmaceutical Biotech's Share Price of today is HK$0.166.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Innovative Pharmaceutical Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Innovative Pharmaceutical Biotech  (HKSE:00399) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Innovative Pharmaceutical Biotech PS Ratio Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Chau Yiu Ting 2101 Beneficial owner
Mao Yumin 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines